Anna Szewczyk Selected Research

Anna Szewczyk Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 02/2018
8	Melanoma (Melanoma, Malignant) 09/2023 - 10/2018
3	Adenocarcinoma 10/2022 - 11/2020
3	Breast Neoplasms (Breast Cancer) 04/2022 - 02/2019
2	Rhabdomyosarcoma 10/2023 - 12/2020
2	Colonic Neoplasms (Colon Cancer) 04/2023 - 06/2021
2	Necrosis 04/2023 - 11/2020
2	Atrophy 10/2022 - 06/2013
2	Amelanotic Melanoma (Amelanotic Melanomas) 07/2021 - 12/2020
2	Glioma (Gliomas) 11/2020 - 11/2019
2	Sarcoma (Soft Tissue Sarcoma) 08/2019 - 02/2018
2	Atopic Dermatitis (Atopic Eczema) 12/2015 - 06/2013
1	Inflammation (Inflammations) 04/2023
1	Lymphoma (Lymphomas) 04/2023
1	Muscular Atrophy (Muscle Atrophy) 10/2022
1	Wounds and Injuries (Trauma) 07/2021
1	Cicatrix (Scar) 07/2021
1	Carcinogenesis 12/2020
1	Ovarian Neoplasms (Ovarian Cancer) 12/2020
1	Prostatic Neoplasms (Prostate Cancer) 11/2020
1	Photosensitivity Disorders (Photodermatitis) 11/2019
1	Glioblastoma (Glioblastoma Multiforme) 11/2019
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2019
1	Shock 01/2019
1	Lung Neoplasms (Lung Cancer) 07/2018
1	Neoplasm Metastasis (Metastasis) 02/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2018
1	Pruritus (Itching) 06/2013

Drug/Important Bio-Agent (IBA)

5	CalciumIBA 04/2023 - 02/2018
5	CurcuminIBA 08/2021 - 01/2019
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 08/2021 - 01/2020
3	Photosensitizing Agents (Photosensitizers)IBA 04/2021 - 11/2019
3	Cisplatin (Platino)FDA LinkGeneric 12/2020 - 01/2018
2	Cytostatic AgentsIBA 10/2023 - 04/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2020 - 11/2020
2	Catechin (Z 7300)IBA 01/2019 - 01/2018
2	AntioxidantsIBA 01/2019 - 07/2018
2	TeaIBA 01/2019 - 01/2018
2	GlucansIBA 10/2018 - 07/2018
2	beta-GlucansIBA 10/2018 - 07/2018
1	LipidsIBA 09/2023
1	Immune Checkpoint InhibitorsIBA 09/2023
1	Immune Checkpoint ProteinsIBA 09/2023
1	betulinIBA 04/2023
1	trimethylenediamineIBA 04/2023
1	Betulinic AcidIBA 04/2023
1	Amino Acids FDA Link 04/2023
1	Lysine (L-Lysine)FDA Link 04/2023
1	OrnithineIBA 04/2023
1	Interleukin-6 (Interleukin 6)IBA 04/2023
1	Daunorubicin (Cerubidine)FDA LinkGeneric 10/2022
1	celastrolIBA 10/2022
1	rhyncophyllineIBA 10/2022
1	Mannich BasesIBA 09/2022
1	Actins (F Actin)IBA 09/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 04/2022
1	gingerolIBA 04/2022
1	Collagen Type III (Type III Collagen)IBA 07/2021
1	Local Anti-Infective Agents (Antiseptics)IBA 07/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2021
1	phytochlorinIBA 04/2021
1	Membrane LipidsIBA 12/2020
1	Estrogens (Estrogen)FDA Link 12/2020
1	Calcium Chloride (Calcium Chloride, Anhydrous)FDA LinkGeneric 12/2020
1	cepharanthineIBA 11/2020
1	PolyestersIBA 01/2020
1	Vinorelbine (Navelbine)FDA LinkGeneric 07/2019
1	Folic Acid (Vitamin M)FDA LinkGeneric 02/2019
1	NanocapsulesIBA 02/2019
1	Glutamic Acid (Glutamate)FDA Link 02/2019
1	LigandsIBA 02/2019
1	honokiolIBA 01/2019
1	Glucose (Dextrose)FDA LinkGeneric 10/2018
1	PolymersIBA 10/2018
1	Glucose Transporter Type 1IBA 10/2018
1	(1-3)(1-4)- beta-glucanIBA 07/2018
1	Calcineurin InhibitorsIBA 06/2013
1	pimecrolimus (Elidel)FDA Link 06/2013
1	Tacrolimus (Prograf)FDA LinkGeneric 06/2013

Therapy/Procedure

9	Therapeutics 10/2023 - 02/2019
4	Photochemotherapy (Photodynamic Therapy) 04/2021 - 11/2019
3	Drug Therapy (Chemotherapy) 10/2023 - 12/2020
1	Aftercare (After-Treatment) 12/2020
1	Optical Devices 02/2019
1	Precision Medicine 02/2019
1	Secondary Prevention 12/2015